Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000092923

Apexbio Technology LLC Rebamipide 90098-04-7 1g
SDP

Catalog No. 5000092923
Encompass_Preferred

Rebamipide (CAS 90098-04-7) is a small molecule administered orally and recognized for its gastroprotective properties Its primary mechanism involves upregulation of cyclooxygenase-2 (COX-2) expression which leads to increased endogenous prostaglandin synthesis particularly prostaglandin E2 (PGE2) thereby enhancing gastric mucosal defense Studies also indicate that rebamipide can inhibit the proliferation of gastric cancer cells This compound is utilized in research investigating the mechanisms underlying gastric mucosal injury peptic ulcer disease gastritis and gastric cancer

Catalog No. 50-000-92923 Supplier Apexbio Technology LLC Supplier No. B20181000
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Rebamipide (CAS 90098-04-7) is a small molecule administered orally and recognized for its gastroprotective properties Its primary mechanism involves upregulation of cyclooxygenase-2 (COX-2) expression which leads to increased endogenous prostaglandin synthesis particularly prostaglandin E2 (PGE2) thereby enhancing gastric mucosal defense Studies also indicate that rebamipide can inhibit the proliferation of gastric cancer cells This compound is utilized in research investigating the mechanisms underlying gastric mucosal injury peptic ulcer disease gastritis and gastric cancer

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.